MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

MDT

86.5

+0.42%↑

A

115.44

+0.79%↑

VEEV

173.86

+0.6%↑

HQY

84.6

+1.48%↑

PHR.US

8.34

-0.6%↓

Search

Atossa Therapeutics Inc

Closed

5.36 5.72

Overview

Share price change

24h

Current

Min

5.07

Max

5.37

Key metrics

By Trading Economics

Income

-2.2M

-11M

Employees

15

EBITDA

-2.7M

-11M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+241.98% upside

Market Stats

By TradingEconomics

Market Cap

-7.8M

41M

Previous open

-0.36

Previous close

5.36

Technical Score

By Trading Central

Confidence

Bullish Evidence

Atossa Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

16 sty 2026, 23:29 UTC

Hot Stocks

Stocks to Watch: Atossa Therapeutics, Union Pacific

Peer Comparison

Price change

Atossa Therapeutics Inc Forecast

Price Target

By TipRanks

241.98% upside

12 Months Forecast

Average 18.33 USD  241.98%

High 25 USD

Low 10 USD

Based on 3 Wall Street analysts offering 12 month price targets forAtossa Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

3 ratings

3

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

0.7955 / 0.898Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Weak Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

help-icon Live chat